Fumio Nishikaku
Direktor/Vorstandsmitglied bei HuLA immune, Inc.
Ursprung des Netzwerks ersten Grades von Fumio Nishikaku
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
MATRIXOME, Inc.
 MATRIXOME, Inc. Miscellaneous Commercial ServicesCommercial Services MATRIXOME, Inc. is a Japanese regenerative medicine company founded in 2015. The company is based in Osaka, Japan and develops regenerative medicine using laminin E8 fragment technology.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Fumio Nishikaku
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| NIPPI,INCORPORATED | Food: Specialty/Candy | Corporate Officer/Principal | |
| Nippi Research Institute of Biomatrix | Corporate Officer/Principal | ||
| KRINGLE PHARMA, INC. | Biotechnology | Director/Board Member | |
| GenAhead Bio, Inc. | Director/Board Member | ||
| MyMetagenome Co. Ltd. | Director/Board Member | ||
KinoPharma, Inc.
 KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
PharmaBio Corp.
 PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Biotechnology | Director/Board Member | |
| TMS CO., LTD. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Japan | 9 |
Sektoral
| Health Technology | 4 |
| Consumer Non-Durables | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 13 |
| Corporate Officer/Principal | 2 |
| President | 2 |
| Chief Executive Officer | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Fumio Nishikaku
- Unternehmensverbindungen
